Earnings ·
Amgen reports Q3 revenue of $10.4B and EPS of $7.08, up 8% and 19%
AMGNAmgen Inc
Amgen reported third-quarter 2026 total revenues of $10.4 billion, an 8% increase from the prior year, driven by volume growth across its commercial portfolio. GAAP diluted earnings per share rose 19% to $7.08, while non-GAAP EPS increased 14% to $6.45. The company generated $3.7 billion in free cash flow and provided full-year 2026 revenue guidance of $38.9 billion to $39.7 billion. Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines.